Clinical Trials in Chicago

Showing 3021-3040 of 9,860 trials

A Novel Probiotic-antibiotic Combination to Prevent Recurrent Urinary Tract Infections

NCT06149676

Patients with recurrent UTI were randomized to receive either the probiotic Sacchromyces Boulardii at enrollment, and the intracellularly active Ciprofloxacin with their first UTI episode after enrollment, or they received standard of care treatment.

Recurrent Uti

Ann & Robert H Lurie Children's Hospital of Chicago35 participantsStarted Feb 2022

Chicago, Illinois, United States

Active Not RecruitingPhase 1/22.2 miles

A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)

NCT05885464

This is a Phase 1/2, multicenter, open-label study to evaluate the safety and efficacy of BEAM-201 in patients with relapsed/refractory T-ALL or T-LL. This study consists of Phase 1 dose-exploration cohorts, Phase 1 dose-expansion cohort(s), a Phase 1 pediatric cohort (will enroll patients ages 1 to \< 12 years), and a Phase 2 cohort.

Lymphoblastic LymphomaT-Cell Lymphoblastic Leukemia/LymphomaLymphoblastic Leukemia

Beam Therapeutics Inc.5 participantsStarted May 2023

Stanford, California, United States • Denver, Colorado, United States • Chicago, Illinois, United States +7 more locations

A Novel Probiotic-antibiotic Combination to Prevent Recurrent Urinary Tract Infections

A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)

Find Trials by Condition in Chicago

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel

Emergency Department-Initiated Buprenorphine Validation Network Trial

Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients

Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee

A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State

Safety and Effectiveness of the Hydrus Microstent

Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)

Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation

Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation

A Study of TAK-861 in Participants With Narcolepsy Type 2

Evaluating Treatment of ADHD in Children with Down Syndrome

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer

Nemaline Myopathy Clinical Research Network (NM-CTRN)

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors